News and Blog

Over 90% of neurological drugs that are successfully tested in animals fail once they reach human clinical trials. Therefore, there is a need for new, clinically relevant, preclinical testing models that mimic the human nervous […]

On July 28, 2020, AxoSim held a webinar which explored the need for new, predictive assays to better assess ADCs’ effects on peripheral neuropathy. Rakesh Dixit, PhD, DABT, elaborated on his 30 plus years of […]

On Tuesday, July 28th, AxoSim is hosting a webinar in collaboration with Rakesh Dixit, PhD, DABT, President and CEO of Bionavigen. This interactive webinar, entitled ADCs and Peripheral Neuropathy: The Need for New, Predictive Assays, […]

On Tuesday, June 30th, 2020 AxoSim held an interactive webinar: NerveSim™ and BrainSim™: Platforms for Neurological Drug Discovery and Toxicology Screening. Lowry Curley, PhD, and Helena Hogberg, PhD delved into the specifics of two drug […]

On Tuesday, June 30th, at 12pm EST AxoSim will be hosting a Webinar: NerveSim™ and BrainSim™ Platforms for Neurological Drug Discovery and Toxicology Screening. This hour long webinar will explore innovative platforms mimicking the CNS […]

On Tuesday, June 30th at 12pm EST, join Helena Hogberg, PhD and Lowry Curley, PhD for an interactive webinar to learn more about innovative platforms for drug discovery mimicking the PNS and CNS. Attendees are […]

May 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by Nerve-on-a-Chip® Using AxoSim’s NerveSim™ Peripheral Neuropathy Assay, AxoSim scientists showed distinct, mechanistic readouts of four […]

AxoSim Chief Science Officer and Co-Founder, Dr. Michael J. Moore, presented Nerve-on-a-Chip pain model at the NIH Tissue Chips Consortium Meeting  March 26, 2020 In 2017, over 47,000 Americans died of opioid overdose, and over […]

Recent study shows AxoSim’s ability to recapitulate results for a client in drug-induced peripheral neuropathy AxoSim was hired by one of the world’s largest pharmaceutical companies to test a drug which was observed to cause […]

Now, more than ever, it’s critical we continue advancing drug development. AxoSim is here to help. Our world has entered a new chapter with the emergence of the COVID-19 pandemic. On behalf of the AxoSim […]